Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic and Hepatobiliary Disorders”

487 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 487 results

Not applicableStudy completedNCT01834300
What this trial is testing

The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non Alcoholic Fatty Liver Disease
University of Liverpool 60
Not applicableStudy completedNCT03593343
What this trial is testing

Hepatic Glycogen and Fat Oxidation

Who this might be right for
Fatty Liver, NonalcoholicMeal TimeFasting+1 more
Maastricht University Medical Center 11
Not applicableLooking for participantsNCT07280390
What this trial is testing

Microplastics, Cirrhosis and Portal Hypertension

Who this might be right for
CirrhosisMicroplasticsPortal Hypertension Related to Cirrhosis+3 more
Post Graduate Institute of Medical Education and Research, Chandigarh 30
Early research (Phase 1)UnknownNCT00935454
What this trial is testing

Hepatocyte Matrix Implant Study

Who this might be right for
Liver DiseaseLiver Cirrhosis
Baermed 10
Not applicableStudy completedNCT03641872
What this trial is testing

A Validation Cohort for ACLF Diagnosis and Prognosis

Who this might be right for
Liver Failure, Acute on ChronicLiver Dysfunction
Hai Li 1,370
Not applicableStudy completedNCT02922751
What this trial is testing

FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)

Who this might be right for
Biliary AtresiaAlagille SyndromeAlpha1 Anti-Trypsin Deficiency+3 more
Arbor Research Collaborative for Health 552
Not applicableStudy completedNCT00887887
What this trial is testing

The Association Between Gene Polymorphisms and Infectious Complications After Liver Surgery

Who this might be right for
Liver Disease
Maastricht University Medical Center 100
Post-approval studies (Phase 4)Study completedNCT05493761
What this trial is testing

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverOsteoporosis, Postmenopausal
Aristotle University Of Thessaloniki 72
Not applicableNot Yet RecruitingNCT06739486
What this trial is testing

Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non Alcholic Fatty Liver DiseaseHepatic SteatosisHepatic Fibrosis+1 more
Assiut University 100
Not applicableNot Yet RecruitingNCT07797101
What this trial is testing

Body-weight Reduction Effect on Portal Hypertension in Compensated Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionFatty Liver Disease+1 more
The Second Affiliated Hospital of Chongqing Medical University 50
Post-approval studies (Phase 4)Looking for participantsNCT05305287
What this trial is testing

Quantifying Hepatic Mitochondrial Fluxes in Humans

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseType 2 DiabetesMitochondrial Metabolism Disorders
The University of Texas Health Science Center at San Antonio 60
Post-approval studies (Phase 4)Looking for participantsNCT07521332
What this trial is testing

Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis

Who this might be right for
CirrhosisEsophageal and Gastric VaricesAscites+3 more
Asian Institute Of Medical Sciences 220
Testing effectiveness (Phase 2)Study completedNCT06442137
What this trial is testing

A Clinical Trial of Chazhu Xiaozhi Decoction Against Non-alcoholic Fatty Liver Disease

Who this might be right for
Hepatic SteatosisSymptoms and Signs
Shanghai Municipal Hospital of Traditional Chinese Medicine 70
Testing effectiveness (Phase 2)Ended earlyNCT00068094
What this trial is testing

The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics

Who this might be right for
Fatty LiverHepatic SteatosisDiabetes Mellitus+1 more
National Center for Complementary and Integrative Health (NCCIH) 30
Not applicableStudy completedNCT02083367
What this trial is testing

Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome

Who this might be right for
Hepatic EncephalopathyCirrhosisNonalcoholic Steatohepatitis+1 more
OSF Healthcare System 12
Not applicableLooking for participantsNCT05477277
What this trial is testing

Adverse Outcomes and Mortality in Liver Transplant

Who this might be right for
End Stage Liver DIseaseSarcopeniaSarcopenic Obesity+1 more
Mayo Clinic 100
Testing effectiveness (Phase 2)Ended earlyNCT00811434
What this trial is testing

Study of Lactulose in Children With Chronic Liver Disease

Who this might be right for
Minimal Hepatic Encephalopathy
Indiana University 16
Not applicableUnknownNCT05500157
What this trial is testing

Assessment of Treatment With Laparoscopic Fenestration or Aspiration Sclerotherapy for Large Symptomatic Hepatic Cysts

Who this might be right for
Liver CystPolycystic Liver DiseaseAutosomal Dominant Polycystic Kidney+1 more
Radboud University Medical Center 70
Early research (Phase 1)Study completedNCT00621881
What this trial is testing

Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects

Who this might be right for
Liver Disease
NicOx 24
Post-approval studies (Phase 4)Study completedNCT03068065
What this trial is testing

Antidiabetic Effects on Intrahepatic Fat

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseType2 Diabetes
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 87
Next Page